The reality is that people and animals will always need medicine, treatments, and other products to live long and comfortable ...

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Zoetis, with a price target of $215.00. The company’s shares closed last Friday at $147.35. Take advantage of ...

Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.850 billion of senior notes, consisting of $850.0 ...

Shares of Zoetis have been roughly average performers over the past decade. The shares seem appealingly valued at recent ...

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the ...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

These two stocks come from completely different industries, but each could boost a long-term investor's returns.

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected to advance at a ...

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected ...

In addition to TD Cowen, Zoetis also received a Buy from William Blair’s Brandon Vazquez in a report issued today. However, on July 31, Stifel Nicolaus maintained a Hold rating on Zoetis (NYSE: ZTS).

Elanco Animal Health (ELAN) stock rises as the company beats Q2 2025 forecasts and raises its full-year outlook. Read more here.